Literature DB >> 23070312

Methodological aspects and the interpretation of clinical trial data: lessons from the TEAR trial.

Roy Fleischmann, Arthur Kavanaugh, Joseph Smolen.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23070312     DOI: 10.1093/rheumatology/kes274

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis.

Authors:  Fernanda S Tonin; Laiza M Steimbach; Leticia P Leonart; Vinicius L Ferreira; Helena H Borba; Thais Piazza; Ariane G Araújo; Fernando Fernandez-Llimos; Roberto Pontarolo; Astrid Wiens
Journal:  Eur J Clin Pharmacol       Date:  2018-07-18       Impact factor: 2.953

Review 2.  Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Authors:  Cécile Gaujoux-Viala; Jackie Nam; Sofia Ramiro; Robert Landewé; Maya H Buch; Josef S Smolen; Laure Gossec
Journal:  Ann Rheum Dis       Date:  2014-01-06       Impact factor: 19.103

3.  Validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology: current practice of bDMARD therapy in rheumatoid arthritis in Austria.

Authors:  Bernhard Rintelen; Jochen Zwerina; Manfred Herold; Franz Singer; Johann Hitzelhammer; Wolfgang Halder; Gabriela Eichbauer-Sturm; Rudolf Puchner; Miriam Stetter; Burkhard F Leeb
Journal:  BMC Musculoskelet Disord       Date:  2016-08-22       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.